Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity.

García-Aguirre I, Alamillo-Iniesta A, Rodríguez-Pérez R, Vélez-Aguilera G, Amaro-Encarnación E, Jiménez-Gutiérrez E, Vásquez-Limeta A, Samuel Laredo-Cisneros M, Morales-Lázaro SL, Tiburcio-Félix R, Ortega A, Magaña JJ, Winder SJ, Cisneros B.

Aging Cell. 2019 Jul 15:e13002. doi: 10.1111/acel.13002. [Epub ahead of print]

2.

Paraneoplastic Granulomatous Vitritis: Elaboration of 8 Cases.

McGrath LA, Mudhar HS, Sheard R, Spiteri-Cornish K, Winder S, Rundle P, Rennie IG.

Ophthalmol Retina. 2019 Jul;3(7):589-596. doi: 10.1016/j.oret.2019.03.003. Epub 2019 Mar 14.

PMID:
31036533
3.

The intracellular domain of β-dystroglycan mediates the nucleolar stress response by suppressing UBF transcriptional activity.

Azuara-Medina PM, Sandoval-Duarte AM, Morales-Lázaro SL, Modragón-González R, Vélez-Aguilera G, Gómez-López JD, Jiménez-Gutiérrez GE, Tiburcio-Félix R, Martínez-Vieyra I, Suárez-Sánchez R, Längst G, Magaña JJ, Winder SJ, Ortega A, Ramos Perlingeiro RC, Jacobs LA, Cisneros B.

Cell Death Dis. 2019 Feb 27;10(3):196. doi: 10.1038/s41419-019-1454-z.

4.

NOVEL OPTICAL COHERENCE TOMOGRAPHY FINDINGS OF A CASE OF SYMPATHETIC OPHTHALMIA AFTER 23-GAUGE VITRECTOMY.

Abdelmaksoud A, Terk-Howe Khoo N, Sears K, Winder S.

Retin Cases Brief Rep. 2019 Jan 16. doi: 10.1097/ICB.0000000000000847. [Epub ahead of print]

PMID:
30668552
5.

Publisher Correction: Retrograde trafficking of β-dystroglycan from the plasma membrane to the nucleus.

Gracida-Jiménez V, Mondragón-González R, Vélez-Aguilera G, Vásquez-Limeta A, Laredo-Cisneros MS, Gómez-López JD, Vaca L, Gourlay SC, Jacobs LA, Winder SJ, Cisneros B.

Sci Rep. 2018 Dec 7;8(1):17785. doi: 10.1038/s41598-018-36661-0.

6.

Are Soy Products Effective in DMD?

Marston G, Winder SJ.

PLoS Curr. 2018 Mar 27;10. pii: ecurrents.md.0439d464ca3344340ac9a7182a6ea28a. doi: 10.1371/currents.md.0439d464ca3344340ac9a7182a6ea28a.

7.

Control of nuclear β-dystroglycan content is crucial for the maintenance of nuclear envelope integrity and function.

Vélez-Aguilera G, de Dios Gómez-López J, Jiménez-Gutiérrez GE, Vásquez-Limeta A, Laredo-Cisneros MS, Gómez P, Winder SJ, Cisneros B.

Biochim Biophys Acta Mol Cell Res. 2018 Feb;1865(2):406-420. doi: 10.1016/j.bbamcr.2017.11.013. Epub 2017 Nov 21.

8.

Retrograde trafficking of β-dystroglycan from the plasma membrane to the nucleus.

Gracida-Jiménez V, Mondragón-González R, Vélez-Aguilera G, Vásquez-Limeta A, Laredo-Cisneros MS, Gómez-López JD, Vaca L, Gourlay SC, Jacobs LA, Winder SJ, Cisneros B.

Sci Rep. 2017 Aug 29;7(1):9906. doi: 10.1038/s41598-017-09972-x. Erratum in: Sci Rep. 2018 Dec 7;8(1):17785.

9.

A role for dystroglycan in the pathophysiology of acute leukemic cells.

Alonso-Rangel L, Benítez-Guerrero T, Martínez-Vieyra I, Cisneros B, Martínez-Tovar A, Winder SJ, Cerecedo D.

Life Sci. 2017 Aug 1;182:1-9. doi: 10.1016/j.lfs.2017.06.004. Epub 2017 Jun 4.

10.

220th ENMC workshop: Dystroglycan and the dystroglycanopathies Naarden, The Netherlands, 27-29 May 2016.

Brown SC, Winder SJ; ENMC DGpathy Study Group.

Neuromuscul Disord. 2017 Apr;27(4):387-395. doi: 10.1016/j.nmd.2016.12.010. Epub 2016 Dec 21. No abstract available.

11.

A Modified Wire Hanging Apparatus for Small Animal Muscle Function Testing.

Hoffman E, Winder SJ.

PLoS Curr. 2016 May 2;8. pii: ecurrents.md.1e2bec4e78697b7b0ff80ea25a1d38be. doi: 10.1371/currents.md.1e2bec4e78697b7b0ff80ea25a1d38be.

12.

γ-Secretase Dependent Nuclear Targeting of Dystroglycan.

Leocadio D, Mitchell A, Winder SJ.

J Cell Biochem. 2016 Sep;117(9):2149-57. doi: 10.1002/jcb.25537. Epub 2016 Mar 31. Erratum in: J Cell Biochem. 2016 Oct;117(10):2436.

13.

Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 Cells.

Escárcega-Tame MA, Martínez-Vieyra I, Alonso-Rangel L, Cisneros B, Winder SJ, Cerecedo D.

PLoS One. 2015 Dec 2;10(12):e0144078. doi: 10.1371/journal.pone.0144078. eCollection 2015.

14.

Dasatinib as a treatment for Duchenne muscular dystrophy.

Lipscomb L, Piggott RW, Emmerson T, Winder SJ.

Hum Mol Genet. 2016 Jan 15;25(2):266-74. doi: 10.1093/hmg/ddv469. Epub 2015 Nov 24.

15.
16.

Laminin promotes metalloproteinase-mediated dystroglycan processing to regulate oligodendrocyte progenitor cell proliferation.

Leiton CV, Aranmolate A, Eyermann C, Menezes MJ, Escobar-Hoyos LF, Husain S, Winder SJ, Colognato H.

J Neurochem. 2015 Nov;135(3):522-38. doi: 10.1111/jnc.13241. Epub 2015 Sep 2.

17.

Association of membrane/lipid rafts with the platelet cytoskeleton and the caveolin PY14: participation in the adhesion process.

Cerecedo D, Martínez-Vieyra I, Maldonado-García D, Hernández-González E, Winder SJ.

J Cell Biochem. 2015 Nov;116(11):2528-40. doi: 10.1002/jcb.25197.

PMID:
26085308
18.

Iris chafing syndrome after scleral-fixated intraocular lens implantation.

Zayed MG, Winder S.

J Cataract Refract Surg. 2014 Nov;40(11):1927-8. doi: 10.1016/j.jcrs.2014.09.019. Epub 2014 Oct 23. No abstract available.

PMID:
25442887
19.

Dystroglycan depletion inhibits the functions of differentiated HL-60 cells.

Martínez-Zárate AD, Martínez-Vieyra I, Alonso-Rangel L, Cisneros B, Winder SJ, Cerecedo D.

Biochem Biophys Res Commun. 2014 Jun 6;448(3):274-80. doi: 10.1016/j.bbrc.2014.04.110. Epub 2014 Apr 30.

PMID:
24792180
20.

The actin binding affinity of the utrophin tandem calponin-homology domain is primarily determined by its N-terminal domain.

Singh SM, Bandi S, Winder SJ, Mallela KM.

Biochemistry. 2014 Mar 25;53(11):1801-9. doi: 10.1021/bi500149q. Epub 2014 Mar 14.

PMID:
24628267
21.

Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.

Mathew G, Mitchell A, Down JM, Jacobs LA, Hamdy FC, Eaton C, Rosario DJ, Cross SS, Winder SJ.

Sci Rep. 2013 Sep 30;3:2792. doi: 10.1038/srep02792.

22.

A role for β-dystroglycan in the organization and structure of the nucleus in myoblasts.

Martínez-Vieyra IA, Vásquez-Limeta A, González-Ramírez R, Morales-Lázaro SL, Mondragón M, Mondragón R, Ortega A, Winder SJ, Cisneros B.

Biochim Biophys Acta. 2013 Mar;1833(3):698-711. doi: 10.1016/j.bbamcr.2012.11.019. Epub 2012 Dec 4.

23.

Resisting sarcolemmal rupture: dystrophin repeats increase membrane-actin stiffness.

Sarkis J, Vié V, Winder SJ, Renault A, Le Rumeur E, Hubert JF.

FASEB J. 2013 Jan;27(1):359-67. doi: 10.1096/fj.12-208967. Epub 2012 Oct 2.

PMID:
23033320
24.

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.

Mitchell A, Mathew G, Jiang T, Hamdy FC, Cross SS, Eaton C, Winder SJ.

Prostate. 2013 Mar;73(4):398-408. doi: 10.1002/pros.22581. Epub 2012 Sep 19.

PMID:
22996647
25.

Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.

Miller G, Moore CJ, Terry R, La Riviere T, Mitchell A, Piggott R, Dear TN, Wells DJ, Winder SJ.

Hum Mol Genet. 2012 Oct 15;21(20):4508-20. Epub 2012 Jul 18.

26.

The inside and out of dystroglycan post-translational modification.

Moore CJ, Winder SJ.

Neuromuscul Disord. 2012 Nov;22(11):959-65. doi: 10.1016/j.nmd.2012.05.016. Epub 2012 Jul 4. Review.

PMID:
22770978
27.

A new twist to coiled coil.

Le Rumeur E, Hubert JF, Winder SJ.

FEBS Lett. 2012 Aug 14;586(17):2717-22. doi: 10.1016/j.febslet.2012.05.004. Epub 2012 May 11. Review.

28.

Dystroglycan and dystroglycanopathies: report of the 187th ENMC Workshop 11-13 November 2011, Naarden, The Netherlands.

Brown SC, Winder SJ.

Neuromuscul Disord. 2012 Jul;22(7):659-68. doi: 10.1016/j.nmd.2012.02.006. Epub 2012 Mar 19. No abstract available.

29.

Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin.

Singh SM, Molas JF, Kongari N, Bandi S, Armstrong GS, Winder SJ, Mallela KM.

Proteins. 2012 May;80(5):1377-92. doi: 10.1002/prot.24033. Epub 2012 Feb 17.

30.

Depletion of the actin bundling protein SM22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells.

Thompson O, Moghraby JS, Ayscough KR, Winder SJ.

BMC Cell Biol. 2012 Jan 18;13:1. doi: 10.1186/1471-2121-13-1.

31.

Spectral Domain OCT: An Aid to Diagnosis and Surgical Planning of Retinal Detachments.

Auger G, Winder S.

J Ophthalmol. 2011;2011:725362. doi: 10.1155/2011/725362. Epub 2011 Dec 29.

32.

Utrophin ABD binds to F-actin in an open conformation.

Broderick MJ, Bobkov A, Winder SJ.

FEBS Open Bio. 2012 Jan 21;2:6-11. doi: 10.1016/j.fob.2012.01.001. Print 2012.

33.

The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish.

Winder SJ, Lipscomb L, Angela Parkin C, Juusola M.

PLoS Curr. 2011 Nov 17;3:RRN1286. doi: 10.1371/currents.RRN1286.

34.

Loss of dystroglycan function in oesophageal cancer.

Parberry-Clark C, Bury JP, Cross SS, Winder SJ.

Histopathology. 2011 Aug;59(2):180-7. doi: 10.1111/j.1365-2559.2011.03930.x.

PMID:
21884196
35.

Letter to the editor.

Reid S, Winder S, Condous G.

J Minim Invasive Gynecol. 2011 Jul-Aug;18(4):545-6. doi: 10.1016/j.jmig.2011.04.010. No abstract available.

PMID:
21777850
36.

Ultrasound diagnosis of ectopic pregnancy.

Winder S, Reid S, Condous G.

Australas J Ultrasound Med. 2011 May;14(2):29-33. doi: 10.1002/j.2205-0140.2011.tb00192.x. Epub 2015 Dec 31.

37.

Sonovaginography: redefining the concept of a "normal pelvis" on transvaginal ultrasound pre-laparoscopic intervention for suspected endometriosis.

Reid S, Winder S, Condous G.

Australas J Ultrasound Med. 2011 May;14(2):21-24. doi: 10.1002/j.2205-0140.2011.tb00190.x. Epub 2015 Dec 31.

38.

The term "pregnancy of unknown location" is here to stay.

Condous G, Winder S, Reid S.

Australas J Ultrasound Med. 2011 May;14(2):17-20. doi: 10.1002/j.2205-0140.2011.tb00189.x. Epub 2015 Dec 31.

39.

Discriminative learning of local image descriptors.

Brown M, Hua G, Winder S.

IEEE Trans Pattern Anal Mach Intell. 2011 Jan;33(1):43-57. doi: 10.1109/TPAMI.2010.54.

PMID:
21088318
40.

Imaging patients with renal colic: a comparative analysis of the impact of non-contrast helical computed tomography versus intravenous pyelography on the speed of patient processing in the Emergency Department.

Quirke M, Divilly F, O'Kelly P, Winder S, Gilligan P.

Emerg Med J. 2011 Mar;28(3):197-200. doi: 10.1136/emj.2009.084806. Epub 2010 Jun 26.

PMID:
20581407
41.

Dystrophin: more than just the sum of its parts.

Le Rumeur E, Winder SJ, Hubert JF.

Biochim Biophys Acta. 2010 Sep;1804(9):1713-22. doi: 10.1016/j.bbapap.2010.05.001. Epub 2010 May 21. Review.

PMID:
20472103
42.

The referral and complete evaluation time study.

Gilligan P, Winder S, Ramphul N, O'kelly P.

Eur J Emerg Med. 2010 Dec;17(6):349-53. doi: 10.1097/MEJ.0b013e328337b9f1.

PMID:
20389251
43.

Impact of admission screening for methicillin-resistant Staphylococcus aureus on the length of stay in an emergency department.

Gilligan P, Quirke M, Winder S, Humphreys H.

J Hosp Infect. 2010 Jun;75(2):99-102. doi: 10.1016/j.jhin.2010.01.019. Epub 2010 Apr 9.

PMID:
20381911
44.

Dystroglycan versatility in cell adhesion: a tale of multiple motifs.

Moore CJ, Winder SJ.

Cell Commun Signal. 2010 Feb 17;8:3. doi: 10.1186/1478-811X-8-3.

45.

Modulation of cell spreading and cell-substrate adhesion dynamics by dystroglycan.

Thompson O, Moore CJ, Hussain SA, Kleino I, Peckham M, Hohenester E, Ayscough KR, Saksela K, Winder SJ.

J Cell Sci. 2010 Jan 1;123(Pt 1):118-27. doi: 10.1242/jcs.047902.

46.

DNW--"did not wait" or "demographic needing work": a study of the profile of patients who did not wait to be seen in an Irish emergency department.

Gilligan P, Joseph D, Winder S, Keeffe FO, Oladipo O, Ayodele T, Asuquo Q, O'Kelly P, Hegarty D.

Emerg Med J. 2009 Nov;26(11):780-2. doi: 10.1136/emj.2008.063388.

PMID:
19850798
47.

Advanced physical assessment: the role of the district nurse.

Baid H, Bartlett C, Gilhooly S, Illingworth A, Winder S.

Nurs Stand. 2009 May 6-12;23(35):41-6.

PMID:
19489401
48.

The Transit/Admission Lounge study.

Gilligan P, O'Kelly P, Hegarty D, Winder S.

Ir Med J. 2009 Jan;102(1):19-21.

PMID:
19284013
49.

The WASP homologue Las17 activates the novel actin-regulatory activity of Ysc84 to promote endocytosis in yeast.

Robertson AS, Allwood EG, Smith AP, Gardiner FC, Costa R, Winder SJ, Ayscough KR.

Mol Biol Cell. 2009 Mar;20(6):1618-28. doi: 10.1091/mbc.E08-09-0982. Epub 2009 Jan 21.

50.

Expression of beta-dystroglycan is reduced or absent in many human carcinomas.

Cross SS, Lippitt J, Mitchell A, Hollingsbury F, Balasubramanian SP, Reed MW, Eaton C, Catto JW, Hamdy F, Winder SJ.

Histopathology. 2008 Nov;53(5):561-6. doi: 10.1111/j.1365-2559.2008.03157.x.

PMID:
18983465

Supplemental Content

Loading ...
Support Center